The p38 mitogen-activated protein kinase (MAPK) isoforms are phosphorylated by a variety of stress stimuli in neurodegenerative disease and act as upstream activators of myriad pathogenic processes. Thus, p38 MAPK inhibitors are of growing interest as possible therapeutic interventions. Axonal dysfunction is an early component of most neurodegenerative disorders, including the most prevalent optic neuropathy, glaucoma. Sensitivity to intraocular pressure at an early stage disrupts anterograde transport along retinal ganglion cell (RGC) axons to projection targets in the brain with subsequent degeneration of the axons themselves; RGC body loss is much later. Here we show that elevated ocular pressure in rats increases p38 MAPK activation in retina, especially in RGC bodies. Topical eye-drop application of a potent and selective inhibitor of the p38 MAPK catalytic domain (Ro3206145) prevented both the degradation of anterograde transport to the brain and degeneration of axons in the optic nerve. Ro3206145 reduced in the retina phosphorylation of tau and heat-shock protein 27, both down-stream targets of p38 MAPK activation implicated in glaucoma, as well as expression of two inflammatory responses. We also observed increased p38 MAPK activation in mouse models. Thus, inhibition of p38 MAPK signaling in the retina may represent a therapeutic target for preventing early pathogenesis in optic neuropathies.
Introduction
The p38 MAPK signaling pathways play a diverse and important role in cellular responses to external stimuli, including stress (Mielke and Herdegen, 2000) . The four highly homologous isoforms of p38 MAPK (α, β, γ, δ) are activated via dual phosphorylation at tyrosine and threonine residues, activating in turn a multitude of downstream cytoplasmic and transcriptional substrates (Ashwell, 2006; Zarubin and Han, 2005) . In neurons, p38 MAPK is activated by a variety of stress-related stimuli, including osmotic shock, excitotoxicity, growth factors, proinflammatory cytokines, and oxidative injury (Bendotti et al., 2005; Harper and LoGrasso, 2001; Mielke and Herdegen, 2000) . As well, many p38 MAPK downstream effects are implicated in neurodegenerative disorders. These include phosphorylation of transcription factors involved in release of inflammatory cytokines, such as ATF2 (activating transcription factor 2), upregulation of pro-apoptotic caspases, and hyperphosphorylation of tau neurofilaments (Ackerley et al., 2004; Munoz and Ammit, 2010) . Thus, p38 MAPK has become increasingly relevant as a potential therapeutic target in neurodegenerative disease (Bendotti et al., 2005) .
Many chronic neurodegenerative disorders demonstrate loss of axonal function as an early hallmark, which is increasingly becoming a target for novel therapeutic interventions (Coleman, 2005; Coleman and Perry, 2002; Whitmore et al., 2005) . Early axonopathy is also observed in glaucoma (Calkins, 2012; Nickells et al., 2012) , the most common optic neuropathy and a leading cause of irreversible blindness worldwide (Quigley and Broman, 2006) . The disease in its most common form involves sensitivity to intraocular pressure (IOP) that results in early degeneration of the retinal ganglion cell (RGC) projection to the brain and later loss of RGC bodies in the retina (Calkins, 2012; Howell et al., 2012) . The only modifiable risk factor for glaucoma is IOP, which is treated by either daily topical hypotensive drugs or surgical intervention when topical drugs fail (reviewed in Shih and Calkins, 2012) . Like other neurodegenerative diseases, one of the earliest signs Abbreviations: ATF2, activating transcription factor 2; ASK1, apoptosis signal-regulating kinase 1; CTB, cholera toxin subunit β; IOP, intraocular pressure; MAPK, mitogen-activated protein kinase; RGC, retinal ganglion cell; SC, superior colliculus; Hsp27, Hsp60, Ro3206145 (1-{4-[3-(4-Fluoro-phenyl)-1H-pyrrolo[3,2-b] pyridin-2-yl]-pyridin-2-ylamino}-propan-2-ol), heat-shock protein 27 and 60; CP, ceruloplasmin; TIMP3, tissue inhibitor of metalloproteinases-3; α-DeTub, α-detyrosinated tubulin; GFAP, glial acidic fibrillary protein.
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